Effects of Botulinum Toxin on Pathophysiology in Spasmodic Dysphonia

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Annals of Otology, Rhinology and Laryngology

• Publication date

  2000-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/000348940010900215PMID 10685573
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A, comparison of bilateral and unilateral botulinum toxin treatments for spasmodic dysphonia

  2004cited by this paper
• Effects of botulinum neurotoxin type A on abducens motoneurons in the cat: alterations of the discharge pattern.

  1997cited by this paper
• Effects of botulinum neurotoxin type A on abducens motoneurons in the cat: ultrastructural and synaptic alterations.

  1997cited by this paper
• Laryngeal Muscle Activity During Speech Breaks in Adductor Spasmodic Dysphonia

  1996cited by this paper
• Analysis of factors affecting botulinum toxin results in spasmodic dysphonia.

  1996cited by this paper
• Histologic assessment of dose‐related diffusion and muscle fiber response after therapeutic botulinum a toxin injections

  1994cited by this paper
• Anatomic considerations in botulinum toxin type a therapy for spasmodic dysphonia

  1994cited by this paper
• Comparison of Muscle Activation Patterns in Adductor and Abductor Spasmodic Dysphonia

  1994cited by this paper
• Botulinum A toxin effects on rat jaw muscle spindles.

  1993cited by this paper
• Unilateral versus bilateral botulinum toxin injections in spasmodic dysphonia: acoustic and perceptual results.

  1993cited by this paper
• Physiological Changes Following Treatment of Speech and Voice Disorders with Botulinum Toxin

  1993cited by this paper
• Quantitative Mapping of the Effect of Botulinum Toxin Injections in the Thyroarytenoid Muscle

  1992cited by this paper
• A comparison of injection techniques using botulinum toxin injection for treatment of the spasmodic dysphonias

  1992cited by this paper
• Botulinum-induced alteration of nerve-muscle interactions in the human orbicularis oculi following treatment for blepharospasm

  1992cited by this paper
• Laryngeal electromyographic activity in adductor and abductor spasmodic dysphonia.

  1991cited by this paper
• Botulinum‐induced alteration of nerve‐muscle interactions in the human orbicularis oculi following treatment for blepharospasm

  1991cited by this paper
• Histologic features of human orbicularis oculi treated with botulinum A toxin.

  1991cited by this paper
• Change in pattern of muscle activity following botulinum toxin injections for torticollis

  1991cited by this paper
• Quantifying the spread of botulinum toxin through muscle fascia

  1991cited by this paper
• Laryngeal Dystonia: A Series with Botulinum Toxin Therapy

  1991cited by this paper
• Therapeutic uses of botulinum toxin.

  1991cited by this paper
• Motor nerve sprouting in human orbicularis muscle after botulinum A injection.

  1990cited by this paper
• 24 – The pathophysiology of spasmodic dysphonia and its modification by botulinum toxin

  1990cited by this paper
• Treatment of speech and voice disorders with botulinum toxin.

  1990cited by this paper
• Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia)

  1988cited by this paper
• Clinical and laboratory characteristics of focal laryngeal dystonia: Study of 110 cases

  1988cited by this paper
• Distant effects of local injection of botulinum toxin

  1987cited by this paper
• Electromyography for Experimentalists

  1986cited by this paper
• Intrinsic laryngeal muscle activity in a spastic dysphonia patient.

  1985influential reference
• Electromyographic Findings in Focal Laryngeal Dystonia (Spastic Dysphonia)

  1985cited by this paper
• Recurrent Laryngeal Nerve Section for Spastic Dysphonia

  1976cited by this paper
• Sensory fibers in the recurrent laryngeal nerve. An electrophysiological study of some laryngeal afferent fibers in the recurrent laryngeal nerve of the cat.

  1969cited by this paper
• Laryngeal myotatic reflexes.

  1966cited by this paper
• Laryngeal Myotatic Reflexes

  1966cited by this paper
• LXII Scientific Papers of the American Laryngological Association

  1965cited by this paper
• Articular reflex mechanisms in the larynx.

  1965cited by this paper
• Muscle spindles in human laryngeal muscles.

  1961cited by this paper
• Muscle spindles in human laryngeal muscles.

  1961cited by this paper

• Minimal Detectable Change of Experienced and Novice Listeners' Ratings of Overall Severity of Voice Quality in Adductor Laryngeal Dystonia.

  2025cites this paper
• Spasmodic Dysphonia

  2025cites this paper
• Patient-Perceived Vocal Effort Immediately Following Voice Tasks in Adductor Laryngeal Dystonia (ADLD).

  2024cites this paper
• ĐÁNH GIÁ CẢI THIỆN CHẤT LƯỢNG GIỌNG TRÊN BỆNH NHÂN RỐI LOẠN PHÁT ÂM CO THẮT THỂ KHÉP SAU ĐIỀU TRỊ BẰNG BOTULINUM TOXIN-A

  2023cites this paper
• Spasmodic Dysphonia and Laryngeal Sense

  2023cites this paper
• Botulinum Neurotoxin Therapy in the Clinical Management of Laryngeal Dystonia

  2022cites this paper
• Spasmodic dysphonia: An overview of clinical features and treatment options.

  2022cites this paper
• Spasmodic dysphonia: introductory phonetic analyses

  2022cites this paper
• Treatment Outcome Measures for Spasmodic Dysphonia: A Systematic Review.

  2022cites this paper
• Globus Pallidus Interna and Ventral Intermediate Nucleus of the Thalamus Deep Brain Stimulation for Adductor Laryngeal Dystonia: a Case Report of Blinded Analyses of Objective Voice Outcomes in 2 Patients

  2022cites this paper
• Laryngeal Sensory Symptoms in Spasmodic Dysphonia.

  2021cites this paper
• Botulinum Toxin Injection for Laryngeal Disorders

  2021cites this paper
• Factors influencing long‐term treatment response to botulinum toxin injection for spasmodic dysphonia

  2020cites this paper
• Retrospective review of dosing trends in botulinum toxin injections for the treatment of adductor spasmodic dysphonia in a long-term cohort

  2020cites this paper
• Altered sensory system activity and connectivity patterns in adductor spasmodic dysphonia

  2020cites this paper
• Laryngeal Dystonia

  2020cites this paper
• Alternating Unilateral Versus Bilateral Injections of Botulinum Toxin for the Treatment of Adductor Spasmodic Dysphonia

  2020cites this paper
• The Use of Botulinum Toxin for Treatment of the Dystonias

  2019cites this paper
• Central Effects of Botulinum Neurotoxin—Evidence from Human Studies

  2019cites this paper
• Outcome Measurement in the Treatment of Spasmodic Dysphonia: A Systematic Review of the Literature.

  2019cites this paper
• Central voice production and pathophysiology of spasmodic dysphonia

  2018cites this paper
• Phenomenology, genetics, and CNS network abnormalities in laryngeal dystonia: A 30‐year experience

  2018cites this paper
• The Expanding Therapeutic Utility of Botulinum Neurotoxins

  2018cites this paper
• Spasmodic Dysphonia.

  2018cites this paper
• Spasmodic Dysphonia: A Review. Part 1: Pathogenic Factors

  2017cites this paper
• The neurosurgical treatment of spasmodic dysphonia : thinking outside the voice box

  2017cites this paper
• [Treatment of laryngeal dystonia with botulinum toxin].

  2017cites this paper
• Direct central nervous system effects of botulinum neurotoxin.

  2017cites this paper
• Vocal Parameters and Self-Perception in Individuals With Adductor Spasmodic Dysphonia.

  2017cites this paper
• Speech–Language Pathology Evaluation and Management of Hyperkinetic Disorders Affecting Speech and Swallowing Function

  2017cites this paper
• Evaluation of type II thyroplasty on phonatory physiology in an excised canine larynx model

  2017cites this paper
• Cortical sensorimotor alterations classify clinical phenotype and putative genotype of spasmodic dysphonia

  2016cites this paper
• Botulinum neurotoxins for the treatment of focal dystonias: Review of rating tools used in clinical trials.

  2015cites this paper
• Office-based laryngeal injection of botulinum toxin for paradoxical vocal fold motion in a child.

  2015cites this paper
• Spasmodische dysfonie: december 2006

  2014cites this paper
• Treatment of spasmodic dysphonia with a neuromodulating electrical implant

  2014cites this paper
• Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders.

  2013cites this paper
• Avaliação vocal e da qualidade de vida em pacientes com distonia laríngea em tratamento com toxina botulínica

  2013cites this paper
• Voice disorders in the workplace: Productivity in spasmodic dysphonia and the impact of botulinum toxin

  2013cites this paper
• Spasmodic Dysphonia: An Evidence-Based Clinical Update

  2013cites this paper
• Abnormal Striatal Dopaminergic Neurotransmission during Rest and Task Production in Spasmodic Dysphonia

  2013cites this paper
• Abnormal structure-function relationship in spasmodic dysphonia.

  2012cites this paper
• Pathophysiology of adductor spasmodic dysphonia: A TMS study

  2012cites this paper
• Combined modality treatment of adductor spasmodic dysphonia.

  2012cites this paper
• A rare case of laryngeal dystonia associated with neurosyphilis: Response to botulinum toxin injection 1

  2011cites this paper
• Spasmodic Dysphonia: a Laryngeal Control Disorder Specific to Speech

  2011influential citation
• A single-centre retrospective review of unilateral and bilateral Dysport® injections in adductor spasmodic dysphonia

  2010cites this paper
• Assessing the effectiveness of botulinum toxin injections for adductor spasmodic dysphonia: clinician and patient perception.

  2010cites this paper
• Disorders of the Upper Airways

  2010cites this paper
• Hemifacial spasm non-motor and motor-related symptoms and their response to botulinum toxin therapy

  2010cites this paper
• Recommendations of the Neurolaryngology Study Group on laryngeal electromyography

  2009cites this paper
• Unilateral versus bilateral thyroarytenoid Botulinum toxin injections in adductor spasmodic dysphonia: a prospective study

  2009influential citation
• Treatment of spasmodic dysphonia with homeopathic medicine: a clinical case report

  2009cites this paper
• Trans-nasal injection of botulinum toxin

  2009cites this paper
• Treatment for spasmodic dysphonia: limitations of current approaches

  2009cites this paper
• Dosage changes in patients with long-term botulinum toxin use for laryngeal dystonia

  2009cites this paper
• A reappraisal of the central effects of botulinum neurotoxin type A: by what mechanism?

  2009cites this paper
• Focal white matter changes in spasmodic dysphonia: a combined diffusion tensor imaging and neuropathological study.

  2008cites this paper
• Injection of Botulinum Toxin into External Laryngeal Muscles in Pediatric Laryngeal Paralysis

  2008cites this paper
• Botulinum toxin injections for the treatment of spasmodic dysphonia (Review)

  2007cites this paper
• Clinical Diagnosis and Management of Dystonia

  2007cites this paper
• Evidence for the effectiveness of botulinum toxin for spasmodic dysphonia from high-quality research designs

  2007cites this paper
• Botulinum toxin for treating spasmodic dysphonia (laryngeal dystonia): a systematic Cochrane review

  2006cites this paper
• Botulinum Toxin in Primary Care Medicine

  2006cites this paper
• Neurophysiological effects of botulinum toxin type a

  2006cites this paper
• Botulinum Toxin Injection and Airflow Stability in Spasmodic Dysphonia

  2006cites this paper
• Alterations in CNS activity induced by botulinum toxin treatment in spasmodic dysphonia: an H215O PET study.

  2006cites this paper
• Common Movement Disorders Affecting the Larynx: A Report from the Neurolaryngology Committee of the AAO-HNS

  2005cites this paper
• Spasmodic Dysphonia: Etiology and Management

  2005cites this paper
• Botulinum toxin injections for the treatment of spasmodic dysphonia.

  2004cites this paper
• Contemporary management of spasmodic dysphonia

  2004cites this paper
• Central effects of botulinum toxin type A: Evidence and supposition

  2004cites this paper
• Historical approaches to the treatment of Adductor-Type Spasmodic Dysphonia (ADSD): Review and tutorial

  2003cites this paper
• Botulinum Toxin: Application Into Acupuncture Points for Migraine

  2003cites this paper
• Histology of Nerves and Muscles in Adductor Spasmodic Dysphonia

  2003cites this paper
• LOCAL ADMINISTRATION OF BOTULINUM TOXIN TYPE-B IN THE EXTERNAL ANAL SPHINCTER OF HORSES PRODUCES TRANSIENT REDUCTION OF PEAK ANAL PRESSURE

  2003cites this paper
• Botulinum toxin for spasmodic dysphonia

  2003cites this paper
• Occupational upper airway disease.

  2002cites this paper
• Botox treatment in adductor spasmodic dysphonia: a meta-analysis.

  2002cites this paper
• Selective suppression of late laryngeal adductor responses by N-methyl-D-aspartate receptor blockade in the cat.

  2002cites this paper
• Stuttering: A Neurodevelopmental Motor Control Disorder

  2002cites this paper
• Other noncosmetic uses of BOTOX.

  2002cites this paper
• The effect of botulinum toxin A on the vocal symptoms of spastic dysarthria: a case study.

  2002cites this paper
• Acoustic measures of symptoms in abductor spasmodic dysphonia.

  2001cites this paper
• Assessment of Posterior Cricoarytenoid Botulinum Toxin Injections in Patients with Abductor Spasmodic Dysphonia

  2001cites this paper
• Other noncosmetic uses of BOTOX.

  2001cites this paper
• Effects of Adductor Muscle Stimulation on Speech in Abductor Spasmodic Dysphonia

  2000cites this paper
• Spasmodic dysphonia: therapeutic options

  2000cites this paper